Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients

Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients

Background A large number of studies have shown that proton pump inhibitors (PPIs) are associated with infection events. Therefore, we retrospectively evaluated the association of PPI therapy with the occurrence of first pneumonia and peritoneal dialysis(PD)-related peritonitis events in the mainten...

Full description

Bibliographic Details
Main Authors: Yujing Zhang, Jiao Li, Zijun Chen, Lingling Liu, Xiaojiang Zhan, Fenfen Peng, Qian Zhou, Xianfeng Wu, Yingsi Zeng, Liya Zhu, Yuxin Xie, Xiaochun Lai, Zebin Wang, Yueqiang Wen, Xiaoran Feng, Jianbo Liang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Renal Failure
Subjects:
Proton pump inhibitors
peritoneal dialysis
pneumonia
peritonitis
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2022.2129064

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2022.2129064

Similar Items